These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5888981)

  • 1. [Studies with 3H-labeled methylhydrazine derivatives].
    Kleibel F
    Nucl Med (Stuttg); 1965; 2():63-7. PubMed ID: 5888981
    [No Abstract]   [Full Text] [Related]  

  • 2. Distribution and excretion studies of procarbazine in animals and man.
    Schwartz DE; Bollag W; Obrecht P
    Arzneimittelforschung; 1967 Nov; 17(11):1389-93. PubMed ID: 5632152
    [No Abstract]   [Full Text] [Related]  

  • 3. Physiological disposition of 1-acetyl-2-picolinoylhydrazine (NSC68626) in rats bearing Walker carcinosarcoma 256.
    Mishra LC; Mead JA
    Cancer Res; 1973 Oct; 33(10):2393-7. PubMed ID: 4741934
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy of experimental meningeal carcinomatosis.
    Ushio Y; Posner JB; Shapiro WR
    Cancer Res; 1977 Apr; 37(4):1232-7. PubMed ID: 844048
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative metabolic studies with Natulan, methylhydrazine and methylamine in rats.
    Schwartz DE
    Experientia; 1966 Apr; 22(4):212-3. PubMed ID: 5955980
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental studies with methylhydrazine derivatives.
    Bollag W
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):158-70. PubMed ID: 5659723
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the mechanism of cytostatic action of methylhydrazine, II].
    Weitzel G; Schneider F; Fretzdorff AM; Durst J; Hirschmann WD
    Hoppe Seylers Z Physiol Chem; 1967 Apr; 348(4):433-42. PubMed ID: 5587962
    [No Abstract]   [Full Text] [Related]  

  • 8. The basis for the disparate sensitivity of L1210 leukemia and Walker 256 carcinoma to a new triazine folate antagonist.
    Skeel RT; Sawicki WL; Cashmore AR; Bertino JR
    Cancer Res; 1973 Nov; 33(11):2972-6. PubMed ID: 4748449
    [No Abstract]   [Full Text] [Related]  

  • 9. Potentiation by clofibrate of in-vivo tumor inhibition by hydrazine sulfate and cytotoxic agents, in Walker 256 carcinosarcoma.
    Gold J
    Cancer Biochem Biophys; 1978; 3(1):41-5. PubMed ID: 552898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygen consumption by acrylamide polymerization for rapid screening of chemotherapeutic agents.
    Tapper D; Johnson R; Folkman MJ
    Surg Forum; 1974; 25(0):87-9. PubMed ID: 4140577
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism of an antineoplastic methylhydrazine derivative in a P815 mouse neoplasm.
    Kreis W
    Cancer Res; 1970 Jan; 30(1):82-9. PubMed ID: 5441083
    [No Abstract]   [Full Text] [Related]  

  • 12. [The use of labelled cells and chemical compounds for the analysis of the mechanism of action of cytotoxic substances].
    Lettré H
    Nucl Med (Stuttg); 1965; 2():3-16. PubMed ID: 5888973
    [No Abstract]   [Full Text] [Related]  

  • 13. Fate of pyruvaldehyde bis(thiosemicarbazone)-35S in male and female rodents.
    Cappuccino JG; Balis ME
    Cancer Res; 1968 Oct; 28(10):1923-31. PubMed ID: 5696926
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo studies on the mechanism of action of the tumor inhibitor vernolepin in the Walker 256 carcinosarcoma.
    Lantz CH; Larner J
    Cancer Biochem Biophys; 1976 Aug; 1(5):229-38. PubMed ID: 975025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental studies of the combined effect of ionizing radiation and of the cytostatic drug Proresid].
    Kärcher KH; Morita K
    Arztl Forsch; 1967 Dec; 21(12):456-63. PubMed ID: 4876563
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental and clinical data on the antitumor action of hydrazine sulfate].
    Seĭts IF; Gershanovich ML; Filov VA; Danova LA; Kondrat'ev VB
    Vopr Onkol; 1975; 21(1):45-52. PubMed ID: 1090085
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative distribution of Baker's antifolate (NSC 139105) in rat tissues after subcutaneous and intravenous injections.
    Yang BC; Ho DH; Brown NS; Benjamin RS; Bodey GP
    J Med; 1980; 11(5-6):413-24. PubMed ID: 6962827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the question of preclinical selection of cytostatics in the area of treatment of human tumors].
    Wüst GP
    Arzneimittelforschung; 1969 May; 19(5):817-9. PubMed ID: 4184536
    [No Abstract]   [Full Text] [Related]  

  • 19. Antitumor effect of N alpha-benzyloxycarbonyl-N,N-bis-(2-halogenethyl)-hydrazide derivatives of amino acids.
    Karaivanova MH; Zakhariev SG; Golovinsky EV
    Neoplasma; 1980; 27(2):137-42. PubMed ID: 7393353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the uptake of 51Cr and 64Cu beta-glycerophosphate complexes by tumours.
    Anghileri LJ
    Nucl Med (Stuttg); 1968 Oct; 7(3):266-78. PubMed ID: 5709696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.